-
It's not unusual for a patient to express a desire to go home when facing the end of life, say two experts interviewed by Medical Ethics Advisor. But the decision-making to allow this can be fraught with complexity, depending on the patient's medical condition and needs.
-
While not every physician or nurse makes a decision to deviate from standard medical practice or rules and regulations governing that practice, it certainly does happen, according to John D. Banja, PhD, professor, department of rehabilitation medicine and medical ethicist, Center for Ethics at Emory University School of Medicine in Atlanta.
-
The United States Conference of Catholic Bishops (USCCB) Secretariat of Pro-Life Activities, Richard Doerflinger, suggests that following the passage of health care reform, "there's still a number of deficiencies in conscience protection."
-
Four founding partners in a public-private collaboration to advance performance measurement in behavioral health on July 21 applauded The Joint Commission's (TJC) announcement of the next phase of the "Hospital-Based Inpatient Psychiatric Hospitals" (HBIPS) core measures initiative.
-
Research institutions increasingly are turning to central IRBs for multisite clinical trials, and this trend probably will accelerate due to recent news that federal regulators are encouraging the change, experts say.
-
Based on a survey of research participants, the office of research compliance and quality improvement at Cedars-Sinai Medical Center in Los Angeles, CA, has come up with these four key areas to demonstrate informed consent.
-
When the federal Office of Human Research Protections raised questions about a quality improvement (QI) initiative to reduce catheter infections in Michigan hospitals in 2007, it reignited a debate over the line between QI and human subjects research necessitating IRB review.
-
-
The Office for Human Research Protections (OHRP) in Washington, DC, is indicating to research institutions that the agency favors the use of centralized IRBs for multisite studies.
-
The Office for Human Research Protections (OHRP) in Washington, DC, recently published letters that explain the agency's revised stand on the use of central or external IRBs.
